Exome sequencing in 200 intellectual disability/autistic patients: New candidates and atypical presentations

22Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

Intellectual disability (ID) and autism spectrum disorder (ASD) belong to neurodevel-opmental disorders and occur in ~1% of the general population. Due to disease heterogeneity, identifying the etiology of ID and ASD remains challenging. Exome sequencing (ES) offers the opportunity to rapidly identify variants associated with these two entities that often co-exist. Here, we performed ES in a cohort of 200 patients: 84 with isolated ID and 116 with ID and ASD. We identified 41 pathogenic variants with a detection rate of 22% (43/200): 39% in ID patients (33/84) and 9% in ID/ASD patients (10/116). Most of the causative genes are genes responsible for well-established genetic syndromes that have not been recognized for atypical phenotypic presentations. Two genes emerged as new candidates: CACNA2D1 and GPR14. In conclusion, this study reinforces the importance of ES in the diagnosis of ID/ASD and underlines that “reverse phenotyping” is fundamental to enlarge the phenotypic spectra associated with specific genes.

Cite

CITATION STYLE

APA

Valentino, F., Bruno, L. P., Doddato, G., Giliberti, A., Tita, R., Resciniti, S., … Ariani, F. (2021). Exome sequencing in 200 intellectual disability/autistic patients: New candidates and atypical presentations. Brain Sciences, 11(7). https://doi.org/10.3390/brainsci11070936

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free